BioHealth News Archive
Success in Maryland: Companies Tell Us about Workforce – MDBIZNews
Here at Commerce, we’re always talking with representatives from Maryland businesses. Recently, we spoke with several business owners and executives about success, specifically asking…
Read MoreJohns Hopkins President Ron Daniels’ contract extended through 2024 – Baltimore Business Journal
Johns Hopkins University President Ronald J. Daniels' contract has been extended through 2024 by the school's Board of Trustees. This is a five-year extension…
Read MoreHighly Skilled Workers Are Flocking To Affordable Markets With A Growing Tech Presence, According To CBRE’s Annual “Scoring Tech Talent” Report – CBRE
Robust influx of millennials in the workforce is a significant factor in this year’s ranking of the top 50 “Tech Talent” markets in the…
Read MoreWexford Science & Technology to be acquired by Ventas in $1.5 billion deal – Baltimore Business Journal
Wexford Science & Technology LLC will soon again be under new ownership. Chicago-based Ventas Inc. has agreed to pay $1.5 billion in cash to…
Read MoreD.C. venture capital firm Updata Partners has raised $280M for new investments
D.C. venture capital powerhouse Updata Partners will announce Thursday that it has raised $280.6 million in new funding. Updata, whose portfolio includes Mashable and…
Read MoreHow to Regrow Your Own Bones – Scientific American
Could lab-grown bones replace tissue grafts and multiple painful surgeries? Nina Tandon is the CEO and co-founder of EpiBone, a Brooklyn-based biotech company that…
Read MoreUniversity of Maryland listed as a top school for female STEM students – SanDiegoUnionTribune.com
More women are studying science, technology, engineering and math at UC San Diego than at any other major college in the country, a recent…
Read MoreWhat will separate the winners and the losers in the immuno-oncology R&D race? – MedCity NewsMedCity News
With the big cancer confab ASCO 2016 fading into memory, R&D teams everywhere are getting back to work on their cancer programs – and…
Read MoreData, IT and patient engagement highlight Cancer Moonshot Summit – MedCity News
The White House’s Cancer Moonshot 2020 is about much more than clinical research. Data, IT and patient engagement are major components. Vice President Joe Biden on Wednesday…
Read MoreCancer Moonshot targets healthcare’s four-letter word: silo – MedCity NewsMedCity News
Vice President Joe Biden, who has personal experience of the heartbreak that cancer causes, has taken on humanity’s mortal enemy and aims to end the…
Read MoreD.C. is a great city for social entrepreneurs. So, what does that actually mean? – Washington Business Journal
Businesses that set out to change the world might want to start in D.C. That’s according to a new study from D.C.-based S&R Foundation’s…
Read MoreBIO Response to Hillary Clinton’s Initiative on Technology & Innovation – Business Wire
The Biotechnology Innovation Organization today released the following statement in response to Democratic Presidential Candidate Hillary Clinton’s Initiative on Technology & Innovation: “As one…
Read MoreCerecor Announces $1.0 Million Research & Development Grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health
Cerecor Inc. (NASDAQ:CERC), a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders, today…
Read MoreOPGEN ANNOUNCES PRICING OF $10 MILLION PRIVATE PLACEMENT
OpGen, Inc. (NASDAQ:OPGN), a precision medicine company using molecular diagnostics and bioinformatics to combat infectious disease, announces the pricing of a private placement of…
Read MoreGlycoMimetics Doses First Patient in Phase 2 Portion of Clinical Trial of GMI-1271 in Newly Diagnosed Acute Myeloid Leukemia
GlycoMimetics, Inc. (NASDAQ: GLYC) today announced dosing of the first patient with newly diagnosed acute myeloid leukemia (AML) in the Phase 2 portion of…
Read More